Elan Corporation, plc (ADR) (ELN) Received Buyout Bid Before Buyback

Page 1 of 2

When Elan Corporation, plc (ADR) (NYSE:ELN) sold its stake in the blockbuster selling multiple sclerosis drug Tysabri to partner Biogen Idec Inc. (NASDAQ:BIIB) in early February, many investors at both companies were left questioning the deal and the motive.

Dublin, Ireland based Elan pocketed $3.25 billion in the sale (on which it will pay little tax) and also inked a royalty payment plan for future sales of the dynamic drug. The hefty payout resulted in a credit downgrade for drug behemoth Biogen, despite the fact it gained sole control over the effective MS treatment. It’s yet to be seen who the clear winner is in this arrangement but Biogen obviously sees big things for Tysabri, which brought in some $1.6 billion in sales in 2012 alone.

Elan Corporation, plc (ADR) (NYSE:ELN)What Elan PLans to Do With the Payout

Analysts and investors have been clamoring for news regarding what Elan intends to do with the hefty takings and now they have some answers. In addition to the $1 billion share buyback announced Feb. 22, the company intends to engage in “a number a strategic transactions” with a share of the proceeds, according to a statement. It will also refinance its $600 million in debt.

Elan CEO Kelly Martin said in a statement, “Understandably, many market participants are looking forward to further clarity around how we intend to deploy the significant upfront payment we will be receiving. We have been making significant progress in this regard and are prepared to move expeditiously, upon close, on the redeployment of capital.”

The share buyback may appease some investors who viewed the Tysabri deal with skepticism. So much so, they sent shares reeling the day the deal was announced it what was the stock’s biggest slide in seven months. At the time Elan said it would share some proceeds with shareholders, but didn’t go into detail.

London’s Breenberg Bank analyst Adrian Howd told Bloomberg, “They’ve now put some numbers around that. And it looks as if the timing of the use of other proceeds, in term of investments in pipeline and new products, is more progressed than some had thought.” Howd recommends buying Elan shares.

Shedding Assets

Elan has been cleaning house. The now stripped-down, streamlined company sold its Elan Drug Technologies unit to Alkermes in 2011. Last December, it spun off Prothena Corporation PLC (NASDAQ:PRTA), its early stage drug research company. Elan surmises the two separated companies will each be worth more apart than conjoined.

Prothena is focused on the discovery and development of antibodies to treat myriad diseases. More specifically it researches disease causing proteins. Potential therapies can be used to treat ailments such as Alzheimer’s, Parkinson’s, and Multiple Sclerosis. The company’s aim is to apply its extensive expertise in generating novel antibodies and then work with strategic partners to eventually bring their findings to clinical trails.

Prothena CEO Dale Schenk said after the spin-off, but before the Tysabri sale, that the promise of Prothena’s drug pipeline “will be more visible to investors now that the company is out from under the umbrella of the Tysabri effort.” Who knew the hit drug was such a drag?

Elan’s Future and Fate

No doubt some investors believed Elan would use the proceeds from the Biogen and Alkermes sale to fund research on its Alzheimer’s disease treatments. Elan is working with giants Johnson & Johnson (NYSE:JNJ) and Pfizer Inc. (NYSE:PFE) on a drug for the dementia-like progressive ailment that causes problems with memory, thinking and behavior. In the U.S., the disease affects more than 5 million, or one in eight, a number that is expected to swell in the near future.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

10 Things The World Can’t Stand About Americans

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!